Trial Profile
Clinical Trials Insight: 700006571
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 09 Jul 2019
Price :
$35
*
At a glance
- Drugs Teriparatide (Primary)
- Indications Osteoporosis; Postmenopausal osteoporosis
- Focus Adverse reactions; Pharmacokinetics
- 31 Oct 2005 New trial record.